Asociación del grupo sanguíneo ABO con complicaciones en covid-19 : revisión sistemática y meta-análisis.

Asociation between abo blood groups and covid-19 complications: systematic review and meta-analysis.

Introducción: los grupos sanguíneos ABO han sido utilizados como marcadores de desenlace en diferentes enfermedades, otorgando al grupo O un factor protector y al A uno de riesgo. Durante el brote de SARS CoV-1 se planteó la posible relación entre riesgo de infección y tipo sanguíneo; se presume que en la pandemia por COVID-19 exista una relación entre determinados desenlaces y los grupos ABO. Objetivo:  determinar la asociación entre los diferentes grupos sanguíneos y los desenlaces de mortalidad, ingreso a cuidados intensivos y requerimiento de intubación orotraqueal (IOT) en población con infección por COVID-19. Materiales y métodos: revisión sistemática y metanálisis entre enero 2020 y marzo 2021 en las bases de datos MEDLINE, EMBASE, SCOPUS, Latindex y LILACS, identificando los desenlaces mencionados en pacientes con COVID-19. Resultados: se incluyeron 16 estudios, la mayoría retrospectivos multicéntricos. Se evidenció que pacientes con grupo sanguíneo A tienen mayor riesgo de mortalidad (OR 1.08 ;1.01-0.17), frente al ingreso a UCI no hubo diferencia estadística significativa entre los grupos sanguíneos. Se encontró que el AB representa un factor de riesgo para intubación orotraqueal (OR 1.42 IC95% 1.02-1.96), en tanto que el A demostró proteger contra este desenlace (OR 0.84 IC95%0.73-0.97). Conclusiones: hay evidencia sobre la relación entre el grupo sanguíneo y los desenlaces, asociada con la infección por SARS-CoV-2. Se requieren estudios prospectivos que evalúen grupo sanguíneo, RH y desenlaces específicos.

1. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc. 2020;323(13):1239–42. doi:10.1001/jama.2020.2648.
2. Wu B, Gu D, Yu J, Yang J, Shen W. Association between ABO blood groups and COVID-19 infection, severityand demise: A systematic review and meta-analysis. Sch Med Nantong Univ Nantong, Jiangsu, PR China. 2020;84:104485. https://doi.org/10.1016/j.meegid.2020.104485.
3. Lesky E. Viennese serological research about the year 1900: its contribution to the development of clinical medicine. Bull New York Acad Med J Urban Heal. 1973;49(2):100–11.
4. Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19: Systematic review and critical appraisal. BMJ. 2020;369:m1328. http://dx.doi.org/10.1136/bmj.m1328.
5. Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015;28(3):801–70. doi:10.1128/CMR.00109-14.
6. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med. 2003;9(5):548–53. doi: 10.1038/nm860.
7. Fry AE, Griffiths MJ, Auburn S, Diakite M, Forton JT, Green A, et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet.[Internet] 2008 Feb 14;17(4):567–76. doi: 10.1093/hmg/ddm331.
8. Chakrani Z, Robinson K, Taye B. Association Between ABO Blood Groups and Helicobacter pylori Infection: A Meta-Analysis. Sci Rep. 2018;8(1):17604. doi: 10.1038/s41598-018-36006-x.
9. Jing W, Zhao S, Liu J, Liu M. ABO blood groups and hepatitis B virus infection: A systematic review and meta-analysis. BMJ Open. 2020;10:e034114. doi: 10.1136/bmjopen-2019-034114.
10. Liao Y, Xue L, Gao J, Wu A, Kou X. ABO blood group-associated susceptibility to norovirus infection: a systematic review and meta-analysis. 2020;81:104245. doi: 10.1016/j.meegid.2020.104245.
11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061–9. doi: 10.1001/jama.2020.1585.
12. Cheng Y, Cheng G, Chui CH, Lau FY. ABO Blood Group and Susceptibilityto Severe Acute Respiratory Syndrome. JAMA - J Am Med Assoc. 2005;293(12):1447–51. doi: 10.1001/jama.293.12.1450-c.
13. Guillon P, Clément M, Sébille V, Rivain JG, Chou CF, Ruvoën-Clouet N, et al. Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008;18(12):1085–93. doi:10.1093/glycob/cwn093.
14. GWAS. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020;383(16):1522–34. http://www.nejm.org/doi/10.1056/NEJMoa2020283.
15. Zeng X, Fan H, Lu D, Huang F, Meng X, Li Z. Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts. 2020;84:104485. https://doi.org/10.1101/2020.04.15.20063107.
16. Zalba S, Luisa M, Galbete A, Etayo M, Ongay E. Infección y trombosis asociada a la COVID-19: posible papel del gruposanguíneo ABO. Med Clin (Barc). 2020;155(8):340–3. doi: 10.1016/j.medcle.2020.06.013.
17. Göker H, Aladağ-Karakulak E, Demiroğlu H, Ayaz CM, Büyükaşik Y, İnkaya AC, et al. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turkish J Med Sci. 2020;50(4):679–83. doi: 10.3906/sag-2005-395.
18. Bhandari P, Durrance RJ, Bhuti P, Salama C. Analysis of ABO and Rh Blood Type Association With Acute COVID-19 Infection in Hospitalized Patients: A Superficial Association Among a Multitude of Established Confounders. J Clin Med Res. 2020;12(12):809–15. doi: 10.14740/jocmr4382.
19. Mullins J, Al-Tarbsheh AH, Chieng H, Chaukiyal P, Ghalib S, Jain E, et al. The association of ABO blood type with the risk and severity of COVID-19 infection. Am J Blood Res. 2021;11(1):53–8.
20. Abdollahi A, Mahmoudi-Aliabadi M, Mehrtash V, Jafarzadeh B, Salehi M. The novel coronavirus sars-cov-2 vulnerability association with abo/rh blood types. Iran J Pathol. 2020;15(3):156–60. doi: 10.30699/IJP.2020.125135.2367
21. Wu Y, Feng Z, Li P, Yu Q. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin Chim Acta. 2020;509:220–223. doi: 10.1016/j.cca.2020.06.026.
22. Latz CA, DeCarlo C, Boitano L, Png CYM, Patell R, Conrad MF, et al. Blood type and outcomes in patients with COVID-19. Ann Hematol. [Internet] 2020;99(9):2113–8. doi: 10.1007/s00277-020-04169-1.
23. Rahim F, Amin S, Bahadur S, Noor M, Mahmood A, Gul H. ABO / Rh-D blood types and susceptibility to corona virus disease-19 in Peshawar, Pakistan. Pakistan J Med Sci. 2021;37(1):1–5. doi: 10.12669/pjms.37.1.3655.
24. Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness. Ann Intern Med. 2021;174(3):308–15. doi: 10.7326/M20-4511.
25. Barnkob MB, Pottegård A, Støvring H, Haunstrup TM, Homburg K, Larsen R, et al. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Adv. 2020;4(20):4990–3. doi: 10.7326/M20-4511.
26. Yaylacı S, Dheir H, İşsever K, Genc AB, Şenocak D, Kocayigit H, et al. The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection. Rev Assoc Med Bras. 2020;66(Suppl 2):86–90. doi: 10.1590/1806-9282.66.S2.86.
27. Zietz M, Zucker J, Tatonetti NP. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv. 2020;1–27. doi: 10.1101/2020.04.08.20058073.
28. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol. 2020;190(1):24–7. doi: 10.1111/bjh.16797.
29. Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–8. doi: 10.1515/cclm-2020-0369.
30. Selden TM, Berdahl TA. COVID-19 and racial/ethnic disparities in health risk, employment, and household composition. Health Aff. 2020;39(9):1624–32. doi: 10.1377/hlthaff.2020.00897.
31. Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? Int J Mol Sci. 2020;21(10):3474. doi: 10.3390/ijms21103474.
32. Liu N, Zhang T, Ma L, Zhang H, Wang H, Wei W, et al. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. Vol. 48, Blood Reviews. Churchill Livingstone. 202148:100785. doi: 10.1016/j.blre.2020.100785.
33. Leaf RK, Al-Samkari H, Brenner SK, Gupta S, Leaf DE. ABO phenotype and death in critically ill patients with COVID-19. Br J Haematol. 2020;190(4):e204-e208. doi: 10.1111/bjh.16984.
34. Dzik S, Eliason K, Morris EB, Kaufman RM, North CM. COVID-19 and ABO blood groups. Vol. 60, Transfusion. 2020;60(8):1883-1884. doi: 10.1111/trf.15946.
35. Shibeeb S, Khan A. ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review. Hematol Transfus Cell Ther. 2021;44(1):70-75. doi: 10.1016/j.htct.2021.07.006.